Ukraine allocates funds for purchase of remdesivir to treat COVID-19 patients

Ukraine allocates funds for purchase of remdesivir to treat COVID-19 patients

The Ukrainian government has allocated funds for the centralized purchase of remdesivir, an antiviral drug used in the treatment of patients with COVID-19, Health Minister Maksym Stepanov has said.

"At a government meeting, a resolution was passed to allocate funds for remdesivir, a drug that is not currently registered in Ukraine, but the law allows us to import and purchase it. As soon as we reach an agreement with the manufacturer, we will immediately submit a draft resolution," Stepanov said at a briefing on Thursday, September 3.

He noted that remdesivir had been included in the COVID-19 national treatment protocol and was showing good results in the treatment of severe symptoms of the disease. At the same time, the minister did not specify the amount of funds allocated by the government.

Stepanov added that this drug is widely used in the United States.

Ukraine recorded 2,430 new daily cases of coronavirus on September 2, bringing the total to 128,228.


Let’s get started read our news at facebook messenger > > > Click here for subscribe

While citing and using any materials on the Internet, links to the website not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2021 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period: